FDA — authorised 7 October 2019
- Application: BLA761125
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Local brand name: BEOVU
- Indication: INJECTABLE — INTRAVITREAL
- Status: approved
🇺🇸 Beovu in United States
FDA authorised Beovu on 7 October 2019
Marketing authorisation
Beovu in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Beovu approved in United States?
Yes. FDA authorised it on 7 October 2019.
Who is the marketing authorisation holder for Beovu in United States?
NOVARTIS PHARMS CORP holds the US marketing authorisation.